rs62617809
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000309585.9(DNASE1L1):c.-351A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.83 ( 27229 hom., 27356 hem., cov: 23)
Exomes 𝑓: 0.77 ( 220394 hom. 281954 hem. )
Failed GnomAD Quality Control
Consequence
DNASE1L1
ENST00000309585.9 5_prime_UTR
ENST00000309585.9 5_prime_UTR
Scores
1
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.267
Publications
8 publications found
Genes affected
DNASE1L1 (HGNC:2957): (deoxyribonuclease 1 like 1) This gene encodes a deoxyribonuclease protein that shows high sequence similarity to DNase I. The encoded protein is localized to the endoplasmic reticulum and modified by N-linked glycosylation. Alternate transcriptional splice variants encoding the same protein have been observed. [provided by RefSeq, Jan 2015]
TAFAZZIN (HGNC:11577): (tafazzin, phospholipid-lysophospholipid transacylase) This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]
TAFAZZIN Gene-Disease associations (from GenCC):
- Barth syndromeInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TAFAZZIN | NM_000116.5 | c.110-17T>C | intron_variant | Intron 1 of 10 | ENST00000601016.6 | NP_000107.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.829 AC: 91819AN: 110698Hom.: 27230 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
91819
AN:
110698
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.774 AC: 847641AN: 1095538Hom.: 220394 Cov.: 60 AF XY: 0.780 AC XY: 281954AN XY: 361522 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
847641
AN:
1095538
Hom.:
Cov.:
60
AF XY:
AC XY:
281954
AN XY:
361522
show subpopulations
African (AFR)
AF:
AC:
25657
AN:
26386
American (AMR)
AF:
AC:
32092
AN:
35062
Ashkenazi Jewish (ASJ)
AF:
AC:
13073
AN:
19339
East Asian (EAS)
AF:
AC:
30174
AN:
30185
South Asian (SAS)
AF:
AC:
51474
AN:
53904
European-Finnish (FIN)
AF:
AC:
28781
AN:
39697
Middle Eastern (MID)
AF:
AC:
3613
AN:
4135
European-Non Finnish (NFE)
AF:
AC:
626077
AN:
840854
Other (OTH)
AF:
AC:
36700
AN:
45976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
9019
18039
27058
36078
45097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18512
37024
55536
74048
92560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.830 AC: 91865AN: 110742Hom.: 27229 Cov.: 23 AF XY: 0.830 AC XY: 27356AN XY: 32964 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
91865
AN:
110742
Hom.:
Cov.:
23
AF XY:
AC XY:
27356
AN XY:
32964
show subpopulations
African (AFR)
AF:
AC:
29484
AN:
30543
American (AMR)
AF:
AC:
9278
AN:
10616
Ashkenazi Jewish (ASJ)
AF:
AC:
1754
AN:
2629
East Asian (EAS)
AF:
AC:
3455
AN:
3455
South Asian (SAS)
AF:
AC:
2506
AN:
2604
European-Finnish (FIN)
AF:
AC:
4276
AN:
5916
Middle Eastern (MID)
AF:
AC:
175
AN:
214
European-Non Finnish (NFE)
AF:
AC:
39214
AN:
52588
Other (OTH)
AF:
AC:
1268
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
546
1092
1639
2185
2731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.